Navigation Links
Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy

Those men who are facing the surgical removal of the prostate due to cancer may hope that a day will come when they need not worry about the post-surgical urinary incontinence.

That's because a team of expert urologic surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has devised a simple, effective means of reconstructing key anatomical structures that ensure continence.

They describe the success of the procedure in the journal Urology.

"Modifying existing tissues, our technique added only a few minutes to standard robotic prostatectomy, yet attained a 95 percent continence rate among patients 16 weeks after their surgeries," explains lead researcher Dr. Ashutosh K. Tewari, director of robotic prostatectomy and outcomes research at NewYork-Presbyterian/Weill Cornell and the Ronald P. Lynch Associate Professor of Urologic Oncology at Weill Cornell Medical College.

"This is a real breakthrough in prostate cancer care, as a significant number of patients have post-prostatectomy urinary incontinence," adds senior researcher Dr. E. Darracott Vaughan, attending urologist at NewYork-Presbyterian/Weill Cornell and The James J. Colt Professor of Urology at Weill Cornell Medical College. He is also Weill Cornell's senior associate dean for clinical affairs.

"Too often, the threat of incontinence can be a key factor in a patient's decision for or against prostatectomy," Dr. Vaughan adds. "A simple intervention like this could make that choice a lot easier."

Prostatectomy involves the excision of the prostate gland, as well as some adjacent tissue, depending on the extent and aggressiveness of the tumor. "Unfortunately, this can weaken structures that control the retention and release of urine from the bladder, such as the puboprostatic ligaments, related muscle and other key anatomy," Dr. Tewari explains. "Together, these structures form a kind of sphincter that must remai
'"/>




Page: 1 2 3

Related medicine news :

1. Innovative device aids in advanced heart failure
2. Innovative footwear may prevent fall in elderly
3. Innovative yeast genome may handle Cancer Clues
4. Innovative solution to help reduce the waiting times for kidney transplants
5. Personalized Medicine and Innovative Pharmaceuticals
6. Creation of Cytomegalovirus Vaccine by an Innovative Method
7. Innovative Method for Creating a Human Cytomegalovirus Vaccine Outlined
8. Innovative treatment for Dementia
9. Innovative treatment for Skin Cancer
10. Innovative Movies Show Real-Time Immune-Cell Activity within Tumors
11. Research In A New Direction To Develop Innovative Psychotropic Drugs
Post Your Comments:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...U.S. hospitals could contribute to the spread of i...low good hygiene practices, according to an offici...ongressional Budget Office report showing saying t...my $675 billion, adds to an increasingly dire pict...
...The National Institute for Health and Clinical Exc... treatment may be denied to drinkers and smokers, ...lifestyle of the patient will play a role in the d...will be cost effective, or even effective upon the...
...Researchers have found that fruitfly gut stem cell...he regulation of cell control in gut of both are a...fruitfly// and humans can help in understanding th...rders and stomach cancers in humans. Insects have ...
...A new study has found that women with breast cance... second cancer not necessarily related to their pr...are published in the December 8, 2005 issue of the...ficial journal of the International Union Against ...
Other Medicine News:Health News:U.S. Hospitals may help Spread Bird Flu Pandemic 2Health News:Women With Breast Cancer At Risk For Developing Second Cancer 2
(Date:10/9/2008)... Top Line Clinical Results Expected in Novembe...all/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announced...sing,for the third of its three pivotal trials to ...n of 12-hour extended-release (ER) ibuprofen for,t...cts to report top-line,results from this pivotal t...
(Date:10/8/2008)... - Findings May Someday Inform Treatments for ..., Oct. 8 /PRNewswire-USNewswire/ -- A protein that...r plays a key role in controlling,the developing n...s precise,connections to form among nerve cells ma...ents who suffer injuries to their nervous system,...
(Date:10/8/2008)... Findings Confirm Potency of Poly-ICR as...FirstCall/ -- Nventa Biopharmaceuticals,Corporatio...eclinical,studies using its proprietary Toll-like ...R), at the World Vaccine Congress 2008 in Lyon, Fr...potent vaccine adjuvant,targeting the Toll-like Re...
(Date:10/7/2008)... Study evaluates the efficacy of new device for de...issed during colonoscopy, ORLANDO, Fla., Oct. 7 /...terology Annual Scientific Meeting in Orlando (ACG..., MD presented results from a,multi-institutional ...Third,Eye(R) Retroscope(R), a new device that is d...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5A South Florida Premiere 22160 1A South Florida Premiere 22160 2Nuvelo to Present at Jefferies 2nd Annual Healthcare Conference 22157 1Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference 22154 1Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference 22154 2BioSpace Launches EuroBio 28TM 29 Online Community 6074 1BioSpace Launches EuroBio 28TM 29 Online Community 6074 2
...also show evidence of additional protection,agains... LOS ANGELES, April 17, 2007 /PRNewswire-FirstCall... vaccine, CERVARIX(R),demonstrated 100 percent ef...ancer-causing human papillomavirus types 16 and 18...l, according to,data presented today at the Americ...
...USINESS WIRE)--Apr 17, 2007 - Adnexus(TM),Therapeu... abstract,"CT-322: A specific VEGFR-2-blocking pro...l tumor models comparable to pan-specific,tyrosine...b" at the,American Association for Cancer Research...e lead author is Irvith Carvajal, Ph.D., with,Eric...
Other Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs).
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity.
The Hancock Standard Mitral bioprosthesis is a portrait of dependability, with predictable results based on 25 years of clinical use. Documented long-term performance makes it an excellent choice for
Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (
Medicine Products: